Materials used in the port catheter cause patients to face an increased risk of infections, according to recently filed AngioDymanics Xcela lawsuit.
Presiding Judge Ohta is expected to appoint a group of AngioDynamics port catheter lawyers to leadership positions, and prepare a group of bellwether cases for early test trials over the next few years.
Broken pieces of the Angiodynamics Vortex chemo port have been deemed too dangerous to remove from the plaintiff’s veins.
Lawsuit comes as a panel of federal judges are scheduled to hear oral arguments later this month, to determine whether all AngioDynamics port catheter lawsuits should be centralized before one judge.
At least 20 AngioDynamics port catheter lawsuits have been filed throughout the federal court system, each involving similar problems where the port catheter fractured, became infected or caused other problems.
Barium sulfate used in the port catheter tubes cause Xcela infections and failures, according to lawsuit filed by an Arizona woman who required surgical removal of the port.
Lawsuit over the Angiodynamics port catheter raises allegations similar to those found in hundreds of Bard PowerPort lawsuits, indicating that device was defectively designed and increases the risk of infections, other injuries.
U.S. JPML has confirmed that Bard PowerPort infection lawsuits raising alternative theories of causation, such as reservoir defects, should be included in the federal MDL established last year in the District of Arizona
MDL panel will hear oral arguments on Jan. 25, to determine whether port reservoir defect lawsuits should be combined with other Bard port lawsuits being pursued over problems with the catheter material.
